Skip to main content
Harold Delasalas, MD, Allergy & Immunology, Duncanville, TX

HaroldCariagaDelasalasMDPharmD, FACP, FACAAI, FAAP

Allergy & Immunology Duncanville, TX

Pediatric Asthma & Allergic Conditions

Medical Director

Dr. Delasalas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Delasalas' full profile

Already have an account?

Education & Training

  • Creighton University
    Creighton UniversityFellowship, Allergy and Immunology, 2011 - 2013
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2011
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 2008

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 2019 - 2026
  • UT State Medical License
    UT State Medical License 2021 - 2026
  • FL State Medical License
    FL State Medical License 2018 - 2026
  • IL State Medical License
    IL State Medical License 2018 - 2026
  • KY State Medical License
    KY State Medical License 2021 - 2025
  • IN State Medical License
    IN State Medical License 2021 - 2025
  • DE State Medical License
    DE State Medical License 2022 - 2025
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Internal Medicine Internal Medicine
  • Join now to see all

Publications & Presentations

PubMed

  • Aquagenic urticaria.
    Thomas B Casale, Jonathan A Olsen, Harold C DelasAlas> ;The Journal of Allergy and Clinical Immunology. in Practice. 2013 Apr 6

Press Mentions

  • Doctors Are Cautiously Optimistic as Austin-Travis County Returns to Stage 4 of COVID-19 Guidelines
    Doctors Are Cautiously Optimistic as Austin-Travis County Returns to Stage 4 of COVID-19 GuidelinesFebruary 27th, 2022